Canada markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.7700+0.0400 (+1.07%)
At close: 04:00PM EST
3.7650 -0.00 (-0.13%)
After hours: 04:08PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close3.7300
Bid3.7600 x 900
Ask3.8700 x 4000
Day's Range3.7300 - 3.9700
52 Week Range3.6100 - 39.4900
Avg. Volume2,236,585
Market Cap229.593M
Beta (5Y Monthly)0.77
PE Ratio (TTM)N/A
EPS (TTM)-11.6890
Earnings DateFeb. 21, 2022 - Feb. 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.36
  • GlobeNewswire

    Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update

    – Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S. Net Product Revenue Estimated Between $12.0 to $12.5 Million – – Company Reiterates Full-Year 2022 Operating Expense Guidance of $220 to $240 Million – ANN ARBOR, Mich., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced preliminary, unaudited fourth-quarter 2021 financial res

  • GlobeNewswire

    Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare Conference

    ANN ARBOR, Mich., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming virtual J.P. Morgan 40th Annual Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. Eastern Time. Event:J.P. Morgan 40th Annual Healthcare ConferenceDate:Thursday, January 13, 2022Format:Presentation and 1:1 MeetingsTime:10:30 a.m. ET Live audio webcasts of these events can be accessed on the investor re

  • Simply Wall St.

    What Type Of Shareholders Own The Most Number of Esperion Therapeutics, Inc. (NASDAQ:ESPR) Shares?

    Every investor in Esperion Therapeutics, Inc. ( NASDAQ:ESPR ) should be aware of the most powerful shareholder groups...